Candida Biofilms: Development, Architecture, and Resistance

Jyotsna Chandra1, Pranab K Mukherjee1

  • 1Center for Medical Mycology and Mycology Reference Laboratory, Department of Dermatology, University Hospitals of Cleveland and Case Western Reserve University, Cleveland, OH 44106.

Microbiology Spectrum
|September 10, 2015
PubMed

Insights

Fungal biofilms, particularly Candida biofilms, are microbial communities on medical devices that resist antimicrobial agents. This review updates knowledge on their development, structure, and resistance mechanisms.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biotechnology

Background:

  • Intravascular device-related infections are frequently linked to microbial biofilms.
  • Candida species are primary fungal pathogens forming biofilms on medical devices and in infections like fungal keratitis.
  • Biofilms exhibit reduced susceptibility to antimicrobials, leading to persistent infections.

Purpose of the Study:

  • To provide an updated overview of fungal biofilms, with a focus on Candida species.
  • To discuss the development, architecture, and resistance mechanisms of these biofilms.

Main Methods:

  • Review of recent technological advancements in biofilm research.
  • Analysis of studies investigating factors influencing biofilm formation (growth time, nutrients, physiological conditions).
  • Synthesis of current knowledge on fungal biofilm characteristics.

Main Results:

  • Biofilm formation is influenced by various environmental and physiological factors.
  • Candida biofilms display complex architecture and specific resistance mechanisms.
  • Novel approaches are enhancing the understanding of biofilm development and markers.

Conclusions:

  • Fungal biofilms pose significant challenges in treating device-related infections.
  • Understanding biofilm development and resistance is crucial for developing effective therapeutic strategies.
  • Continued research is essential for combating persistent fungal biofilm infections.